EE Impact

Boiron

France · Pharma & Healthcare

LeaveRussia detail: Pausing Investments

Operations suspended

Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world.

Status last verified 03/08/2026Source checked 05/05/2022Company website ↗LeaveRussia profile ↗

Decision trail

Decision date 13/04/2022 · Reference ↗

Boiron frozes investments, stopped advertising campaigns, canceled new product launches and stopped its clinical trial activities in Russia.

Local stats (LeaveRussia)

Assets(RF), mln.USD
26
Capital(RF), mln.USD
21
Glob.Revenue, mln.USD
481
Revenue(RF), mln.USD
22
Staff(RF), 2021
164
Taxes(RF), mln.USD
2

Status history since 2022

  1. 03/08/2026 suspended · Imported from KSE LeaveRussia

Exposure profile

Full exposure profile is a Professional feature

Energy, transport and commodity exposure, supplier/customer links in the region and sanctioned-party proximity.

Upgrade to Professional
Statuses, logos and narrative notes are compiled from public reporting and the KSE LeaveRussia project. Found an error? See our corrections policy.